ADMA Adma Biologics Inc

3.555
0.065 (1.86%)
Last Updated: 10:52:44
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
Adma Biologics Inc ADMA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.065 1.86% 3.555 10:52:44
Open Price Low Price High Price Close Price Prev Close
3.51 3.51 3.6075 3.49
more quote information »

Recent News

Date Time Source Heading
9/26/20238:37IHNWFeatured1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience
8/30/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/24/202319:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202317:09EDGAR2Form 144 - Report of proposed sale of securities
8/18/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/18/202312:58EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
8/17/202321:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202320:47EDGAR2Form 144 - Report of proposed sale of securities
8/09/202317:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:15EDGAR2Form 8-K - Current report
8/09/202316:05GLOBEADMA Biologics Announces Second Quarter 2023 Financial..
8/02/202307:00GLOBEADMA Biologics to Report Second Quarter 2023 Financial..
7/19/202307:30EDGAR2Form 8-K - Current report
7/05/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202316:05GLOBEADMA Biologics Announces First Quarter 2023 Financial..
5/03/202307:00GLOBEADMA Biologics to Report First Quarter 2023 Financial..
5/02/202307:00GLOBEADMA Biologics Announces Amendment to Credit Agreement
3/23/202316:05GLOBEADMA Biologics Announces Fourth Quarter and Full Year 2022..
3/16/202307:00GLOBEADMA Biologics to Report Fourth Quarter and Full Year 2022..
2/08/202307:00GLOBEADMA BioCenters Receives FDA Approval for its Eighth Plasma..
1/17/202307:00GLOBEADMA Biologics Announces Preliminary Fourth Quarter and Full..
12/13/202207:00GLOBEADMA Biologics Announces FDA Approval for Room Temperature..
12/09/202216:05GLOBEADMA Biologics Announces Closing of $69 Million Public..
12/07/202208:45GLOBEADMA Biologics Announces Pricing of Public Offering for $60..
12/06/202216:05GLOBEADMA Biologics Announces Proposed Public Offering of Common..
12/06/202216:01GLOBEADMA Biologics Announces Preliminary Fourth Quarter 2022..
11/11/202206:35TRMNH.C. Wainwright Sticks to Its Buy Rating for ADMA Biologics..
11/09/202216:05GLOBEADMA Biologics Announces Third Quarter 2022 Financial..
11/02/202207:00GLOBEADMA Biologics to Report Third Quarter 2022 Financial..
10/31/202207:00GLOBEADMA BioCenters Receives FDA Approval for its Seventh Plasma..